Improving Genome Editing with Enhanced CRISPR-Cas Nucleases
Some of the greatest hurdles to the successful application of CRISPR-Cas technology in the clinic include suboptimal specificity, activity, and targeting range. In this webinar, Dr. Benjamin Kleinstiver presents a brief overview of genome editing and CRISPR technology. He then describes his lab's efforts to engineer enhanced CRISPR-Cas nucleases for improved genome editing specificity and discusses how these technologies can translate to more efficient tools and disease treatments.
Publish Date:
May 21, 2019
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells
Publish Date: June 26, 2018 -
Re-Creating Disease with Kidney Organoids and CRISPR
Publish Date: July 12, 2018 -
Using CRISPR/Cas9 to Model Stem Cell Organization and Dynamics
Publish Date: August 25, 2017
Explore Our Products
-
Custom-designed CRISPR RNA for guide RNA generation in CRISPR-Cas9 genome editing -
Cas9 nuclease for the generation of double-strand breaks in CRISPR-Cas9 genome editing -
Trans-activating crRNA for guide RNA generation in CRISPR-Cas9 genome editing -
Enhanced green fluorescent protein (eGFP)-tagged Cas9 nuclease for the generation of double-strand breaks in CRISPR-Cas9 genome editing
